Grove Biopharma
PrivateLast Round
Series A
Apr 23, 2025
Total Funding Raised
$34.25M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Grove Biopharma is a biotechnology company that develops novel therapeutics targeting intracellular protein-protein interactions using its proprietary Bionic Biologics™ platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Grove Biopharma Comparables
Compare Grove Biopharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Libera Bio | 75% | |
| Dunad Therapeutics | 73% | |
| C4 Therapeutics | 69% | |
Grove Biopharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 23, 2025 | ||||
| Grant | Jul 15, 2023 | ||||
| Seed | May 10, 2021 |
Key People
Founding team and executive leadership
Grove Biopharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| U.S. Department of Health and Human Services | Grant |
| DCVC Bio | Series A |
| InVivium Capital | Series A |
| Mansueto Office | Series A |
| Walder Ventures | Seed, Series A |
| Skydeck Capital | Seed |
| Portal Innovations | Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 30, 2026
Grew 50% QoQ, from 20 to 30 employees.
- Aug 15, 2025
Will participate in the Materials Biology symposium at the ACS Fall 2025 Scientific meeting.
Grove Biopharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Grove Biopharma's valuation, stock price, and market status.